Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion type Assertion NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_head.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion description "[However, the effects of PPAR agonists on steatosis that is a common pathology associated with NAFLD, remain largely controversial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_provenance.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion evidence source_evidence_literature NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_provenance.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion SIO_000772 24534255 NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_provenance.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion wasDerivedFrom befree-20150227 NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_provenance.
- NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_assertion wasGeneratedBy ECO_0000203 NP636567.RAxT2xznk7JuYQiq3VsD0IApouFE6BXYRTJMknBnW5MXs130_provenance.